(-0.68%) 5 073.00 points
(-0.62%) 38 441 points
(-1.03%) 17 483 points
(0.10%) $82.89
(0.79%) $1.666
(0.10%) $2 340.80
(0.23%) $27.41
(-0.08%) $915.10
(-0.22%) $0.932
(-0.36%) $10.94
(-0.36%) $0.799
(-0.31%) $92.03
Live Chart Being Loaded With Signals
FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system...
Stats | |
---|---|
Today's Volume | 50 500.00 |
Average Volume | 97 893.00 |
Market Cap | 25.62B |
EPS | ¥19.18 ( 2024-02-13 ) |
Next earnings date | ( ¥0 ) 2024-05-08 |
Last Dividend | ¥4.00 ( 2023-06-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 24.20 |
ATR14 | ¥0.757 (0.08%) |
Volume Correlation
FINDEX Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
FINDEX Inc. Correlation - Currency/Commodity
FINDEX Inc. Financials
Annual | 2023 |
Revenue: | ¥5.19B |
Gross Profit: | ¥3.33B (64.13 %) |
EPS: | ¥41.31 |
Q4 | 2023 |
Revenue: | ¥1.72B |
Gross Profit: | ¥1.20B (69.70 %) |
EPS: | ¥19.18 |
Q3 | 2023 |
Revenue: | ¥1.23B |
Gross Profit: | ¥852.01M (69.55 %) |
EPS: | ¥11.05 |
Q2 | 2023 |
Revenue: | ¥997.44M |
Gross Profit: | ¥565.62M (56.71 %) |
EPS: | ¥3.29 |
Financial Reports:
No articles found.
FINDEX Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥6.50 (N/A) |
¥0 (N/A) |
¥4.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥0.250 | 2011-12-28 |
Last Dividend | ¥4.00 | 2023-06-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 23 | -- |
Total Paid Out | ¥74.42 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.66 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.95 | |
Div. Directional Score | 8.10 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
7970.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7198.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6454.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
5449.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4441.T | Ex Dividend Junior | 2023-10-30 | Annually | 0 | 0.00% | |
3636.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
2882.T | Ex Dividend Junior | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
1663.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
9755.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
8804.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.204 | 1.500 | 5.92 | 8.88 | [0 - 0.5] |
returnOnAssetsTTM | 0.178 | 1.200 | 4.05 | 4.86 | [0 - 0.3] |
returnOnEquityTTM | 0.243 | 1.500 | 8.41 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 6.48 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 5.97 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.32 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0558 | -1.500 | 9.07 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 2 394.51 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 20.20 | 2.00 | 3.27 | 6.53 | [0 - 30] |
freeCashFlowPerShareTTM | 20.20 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0685 | -1.500 | 9.73 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.641 | 1.000 | 2.64 | 2.64 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.288 | 1.000 | 6.23 | 6.23 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.564 | 1.000 | 2.42 | 2.42 | [0.2 - 2] |
assetTurnoverTTM | 0.875 | 0.800 | 7.50 | 6.00 | [0.5 - 2] |
Total Score | 11.26 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.21 | 1.000 | 7.66 | 0 | [1 - 100] |
returnOnEquityTTM | 0.243 | 2.50 | 8.98 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 20.20 | 2.00 | 3.27 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.300 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 20.20 | 2.00 | 3.27 | 6.53 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.123 | 1.500 | 5.84 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0998 | 1.000 | -0.00558 | 0 | [0.1 - 0.5] |
Total Score | 4.95 |
FINDEX Inc.
FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators